| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |